I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Veerman, G. D.Marijn
304
results:
Search for persons
X
Format
Online (304)
Mediatypes
E-Books (1)
Articles (Online) (272)
Bookchapter (Online) (3)
OpenAccess-fulltext (28)
Languages
english (284)
german (1)
more...
dutch (2)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Quantitative modeling of tumor dynamics and development of ..:
Yin, Anyue
;
Veerman, G. D. Marijn
;
van Hasselt, Johan G. C.
...
CPT: Pharmacometrics & Systems Pharmacology. 13 (2024) 4 - p. 612-623 , 2024
Link:
https://doi.org/10.1002/..
?
2
Osimertinib Plasma Trough Concentration in Relation to Brai..:
Gulikers, Judith L.
;
Veerman, G.D. Marijn
;
Jebbink, Merel
...
JTO Clinical and Research Reports. 5 (2024) 4 - p. 100656 , 2024
Link:
https://doi.org/10.1016/..
?
3
Incidence of Bone Metastases and Skeletal-Related Events in..:
Brouns, Anita J.W. M.
;
van Veelen, Ard
;
Veerman, G. D. Marijn
...
JTO Clinical and Research Reports. 4 (2023) 5 - p. 100513 , 2023
Link:
https://doi.org/10.1016/..
?
4
Design and statistics of pharmacokinetic drug-drug, herb-dr..:
Lanser, Daan A.C.
;
Van der Kleij, Maud B.A.
;
Veerman, G.D. Marijn
...
Biomedicine & Pharmacotherapy. 163 (2023) - p. 114823 , 2023
Link:
https://doi.org/10.1016/..
?
5
Quantitation of osimertinib, alectinib and lorlatinib in hu..:
de Leeuw, Simon P.
;
de Bruijn, Peter
;
Koolen, Stijn L.W.
...
Journal of Pharmaceutical and Biomedical Analysis. 225 (2023) - p. 115233 , 2023
Link:
https://doi.org/10.1016/..
?
6
Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Ca..:
Pruis, Melinda A.
;
Veerman, G.D. Marijn
;
Hassing, H. Carlijne
...
JACC: CardioOncology. 5 (2023) 1 - p. 102-113 , 2023
Link:
https://doi.org/10.1016/..
?
7
Analysis of Serious Weight Gain in Patients Using Alectinib..:
de Leeuw, Simon P.
;
Pruis, Melinda A.
;
Sikkema, Barend J.
...
Journal of Thoracic Oncology. 18 (2023) 8 - p. 1017-1030 , 2023
Link:
https://doi.org/10.1016/..
?
8
Influence of germline variations in drug transporters ABCB1..:
Veerman, G.D. Marijn
;
Boosman, Rene J.
;
Jebbink, Merel
...
eClinicalMedicine. 59 (2023) - p. 101955 , 2023
Link:
https://doi.org/10.1016/..
?
9
Exploring the impact of patient‐specific clinical features ..:
van Veelen, Ard
;
Veerman, G. D. Marijn
;
Verschueren, Marjon V.
...
International Journal of Cancer. 154 (2023) 2 - p. 332-342 , 2023
Link:
https://doi.org/10.1002/..
?
10
The influence of green tea extract on nintedanib's bioavail..:
Veerman, G.D.Marijn
;
van der Werff, Sanne C.
;
Koolen, Stijn L.W.
...
Biomedicine & Pharmacotherapy. 151 (2022) - p. 113101 , 2022
Link:
https://doi.org/10.1016/..
?
11
Influence of esomeprazole on the bioavailability of afatini..:
Veerman, G.D. Marijn
;
Hurkmans, Daan P.
;
Paats, Marthe S.
...
Biomedicine & Pharmacotherapy. 155 (2022) - p. 113695 , 2022
Link:
https://doi.org/10.1016/..
?
12
Clinical implications of germline variations for treatment ..:
Heersche, Niels
;
Veerman, G.D. Marijn
;
de With, Mirjam
...
Drug Resistance Updates. 62 (2022) - p. 100832 , 2022
Link:
https://doi.org/10.1016/..
?
13
Improving the tolerability of osimertinib by identifying it..:
Agema, Bram C.
;
Veerman, G. D. Marijn
;
Steendam, Christi M. J.
...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211032 , 2022
Link:
https://doi.org/10.1177/..
?
14
To quantify the small-molecule kinase inhibitors ceritinib,..:
Veerman, G.D. Marijn
;
de Bruijn, Peter
;
Dingemans, Anne-Marie C.
..
Journal of Pharmaceutical and Biomedical Analysis. 193 (2021) - p. 113733 , 2021
Link:
https://doi.org/10.1016/..
?
15
Randomized phase III study of docetaxel versus docetaxel pl..:
Steendam, Christi M.J.
;
Peric, Robert
;
van Walree, Nico C.
...
Lung Cancer. 160 (2021) - p. 44-49 , 2021
Link:
https://doi.org/10.1016/..
1-15